文献速递皮肤肿瘤

CDKN2A胚系变异与黑色素瘤家族成员痣表型的关联

Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.
PubMed 文献 · J Invest Dermatol · 2017-08-19

基于GenoMEL数据,研究CDKN2A突变携带与黑色素瘤家族血亲成员2mm、5mm及非典型痣计数的关系。携带致病突变者非典型痣患病率更高(OR=1.64),但2mm和5mm痣无显著关联;非病例家属中突变携带者同时具有三类痣计数≥中位数的可能性近三倍(OR=2.91)。结果支持未知致痣基因与CDKN2A共遗传并影响癌变的假说。

要点

  • CDKN2A致病突变携带与黑色素瘤家族成员非典型痣计数升高相关。
  • 2mm和5mm普通获得性痣计数与CDKN2A突变携带无显著关联。
  • 非病例家属中突变携带者同时具备三类痣高计数的风险近三倍。

核心结论

  • CDKN2A致病突变携带与黑色素瘤家族成员非典型痣计数升高相关,但与2mm和5mm痣计数无显著关联。
  • 非病例家属中突变携带者同时具有三类痣计数≥中位数的可能性近三倍,支持未知致痣基因与CDKN2A共遗传并影响癌变的假说。

研究设计与样本

  • 基于GenoMEL数据,纳入黑色素瘤家族的血亲成员,比较CDKN2A突变携带者与非携带者的痣计数。

主要发现

  • 携带致病突变者非典型痣患病率高于非携带者(OR=1.64;95%CI=1.18-2.28)。
  • 2mm痣(OR=1.06;95%CI=0.92-1.21)和5mm痣(OR=1.26;95%CI=0.94-1.70)与突变携带无显著关联。
  • 按病例状态分层,非病例家属中突变携带者同时具有三类痣计数≥中位数的可能性近三倍(OR=2.91;95%CI=1.75-4.82)。

临床怎么用

  • 对黑色素瘤家族成员评估时,CDKN2A突变携带状态可提示非典型痣计数升高风险。
  • 非病例家属中突变携带者需关注多类痣同时高计数的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated with increased atypical nevus counts. However, a clear relationship between pathogenic CDKN2A mutation carriage and other nevus phenotypes including counts of common acquired nevi has not yet been established. Using data from GenoMEL, we investigated the relationships between CDKN2A mutation carriage and 2-mm, 5-mm, and atypical nevus counts among blood-related members of melanoma families. Compared with individuals without a pathogenic mutation, those who carried one had an overall higher prevalence of atypical (odds ratio = 1.64; 95% confidence interval = 1.18-2.28) nevi but not 2-mm nevi (odds ratio = 1.06; 95% confidence interval = 0.92-1.21) or 5-mm nevi (odds ratio = 1.26; 95% confidence interval = 0.94-1.70). Stratification by case status showed more pronounced positive associations among non-case family members, who were nearly three times (odds ratio = 2.91; 95% confidence interval = 1.75-4.82) as likely to exhibit nevus counts at or above the median in all three nevus categories simultaneously when harboring a pathogenic mutation (vs. not harboring one). Our results support the hypothesis that unidentified nevogenic genes are co-inherited with CDKN2A and may influence carcinogenesis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Taylor NJ, Mitra N, Goldstein AM, et al. Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. J Invest Dermatol. 2017. PMID: 28830827. doi:10.1016/j.jid.2017.07.829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。